Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C26H27BrF3N5O2.ClH |
| Molecular Weight | 614.885 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CNC[C@@H](NC(=O)C1=CC=C(C=C1F)C2=C(N)N=CC(=N2)[C@H]3CC[C@H](O)[C@@H](F)C3)C4=CC(Br)=CC(F)=C4
InChI
InChIKey=BTUJMQIKTCOSFK-XKNHYIDFSA-N
InChI=1S/C26H27BrF3N5O2.ClH/c1-32-11-21(15-6-16(27)10-17(28)7-15)35-26(37)18-4-2-14(9-19(18)29)24-25(31)33-12-22(34-24)13-3-5-23(36)20(30)8-13;/h2,4,6-7,9-10,12-13,20-21,23,32,36H,3,5,8,11H2,1H3,(H2,31,33)(H,35,37);1H/t13-,20-,21+,23-;/m0./s1
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C26H27BrF3N5O2 |
| Molecular Weight | 578.424 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
972 ng/mL CLINICAL TRIAL https://clinicaltrials.gov/study/NCT02711345 |
200 mg 1 times / day multiple, oral dose: 200 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
RINETERKIB plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
494 ng/mL CLINICAL TRIAL https://clinicaltrials.gov/study/NCT02711345 |
200 mg single, oral dose: 200 mg route of administration: Oral experiment type: SINGLE co-administered: |
RINETERKIB plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
14600 ng × h/mL CLINICAL TRIAL https://clinicaltrials.gov/study/NCT02711345 |
200 mg 1 times / day multiple, oral dose: 200 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
RINETERKIB plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
16.8 h CLINICAL TRIAL https://clinicaltrials.gov/study/NCT02711345 |
200 mg 1 times / day multiple, oral dose: 200 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
RINETERKIB plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:09:21 GMT 2025
by
admin
on
Mon Mar 31 23:09:21 GMT 2025
|
| Record UNII |
8RS453RBHM
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
8RS453RBHM
Created by
admin on Mon Mar 31 23:09:21 GMT 2025 , Edited by admin on Mon Mar 31 23:09:21 GMT 2025
|
PRIMARY | |||
|
154572843
Created by
admin on Mon Mar 31 23:09:21 GMT 2025 , Edited by admin on Mon Mar 31 23:09:21 GMT 2025
|
PRIMARY | |||
|
1715025-34-5
Created by
admin on Mon Mar 31 23:09:21 GMT 2025 , Edited by admin on Mon Mar 31 23:09:21 GMT 2025
|
NON-SPECIFIC STOICHIOMETRY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
